Lupus registry study for adults
Part of Immune system & allergy, Skin clinical trials.
This is a registry study for people living with systemic lupus erythematosus (lupus). By joining, you help researchers collect information about lupus to better understand the disease and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years of age or older.
- You must have a confirmed diagnosis of systemic lupus erythematosus (lupus).
- You must sign a written consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects health data from people recently diagnosed with lupus to improve treatment and care. It is a registry study, not a drug-testing trial, and aims to understand how patients fare over time.
This study creates a registry for people with lupus and their families. It helps researchers learn more about lupus and improve care. You or your child can join if you have a lupus diagnosis.
This study keeps a long-term record of people with lupus (systemic lupus erythematosus) and collects samples so researchers can study the disease better. You may be able to join if you meet lupus diagnosis criteria, are not pregnant, and can follow the study visits and consent process.
This is a registry that follows adults with newly diagnosed lupus (within 5 years) to better understand the disease and care needs over time. It may help researchers and doctors learn what to expect early in lupus and improve future treatment planning.
This registry tracks the safety and effectiveness of lupus treatments over time. If you have SLE and are starting a new treatment or were recently diagnosed, joining helps doctors learn which medicines work best.
This study follows adults with systemic lupus erythematosus (lupus) to better understand the condition over time. If you meet common lupus diagnosis standards, you may be able to join—there’s no limit on when you were diagnosed.
Hear when a new Systemic Lupus Erythematous (SLE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.